Click on the session titles below to view the lectures for each session:
- Asia-Pacific (APSC) Cardiac Problems in Pregnancy (CPP) 2023 Joint Session
- Abu Dhabi – United Arab Emirate Cardio Obstetric Joint Clinic
- The International Society of Obstetric Medicine Session
- Cardio Obstetrics
- Covid-19
- Risk Prediction and Mortality
- Infertility and Contraceptives in Women with Cardiac Disease IVF
- Pregnancy and Medical problems
- General
- Registries
- Cardiomyopathy, Myocarditis Heart Failure and Pericardial Disease
Asia-Pacific (APSC) Cardiac Problems in Pregnancy (CPP) 2023 Joint Session: Valvular Heart Disease in Pregnancy
Organized by:
Wael Almahmeed
Cardiology, Abu Dhabi, United Arab Emirates
Bashir Taha Salih
Obstetric medicine Abu Dhabi, United Arab Emirates
Prenatal Assessment
Wanwarang Wongcharoen
Internal Medicine, Chiang Mai University, Thailand
Anticoagulation Management
Geetha Kandavello
Malaysia
Valvular Intervention during Pregnancy
Low Ting Ting
Singapore
Aortic Stenosis in Pregnancy
Doreen DeFaria Yeh
Cardiology, Massachusetts General Hospital, Boston, USA
Mitral Stenosis: Pregnancy Risks and Management
Candice Silversides
Mount Sinai Hospital, Toronto, Canada
Indications for Intervention for Women with Valvular Heart Disease during Pregnancy
Uri Elkayam
University of Southern California, Los Angeles, USA
Abu Dhabi – United Arab Emirate Cardio Obstetric Joint Clinic – Case Presentations and Panel Discussion
Panel:
Wael Al Mahmeed, Heart, Vascular & Thoracic Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates
Saleema Wani, Obstetrics & Gynecology Corniche Hospital, Abu Dhabi, United Arab Emirates
Bashir Taha Salih, Obstetric medicine, Corniche Hospital, Abu Dhabi, United Arab Emirates
Tarek El Ansari, Obstetric Anesthesia, Corniche Hospital, Abu Dhabi, United Arab Emirates
Ghadeera Al Mansoori, Cardiology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates
Sam Siu, Western University, London, Canada
Marie-Louise Meng, Duke University Medical Center, Durham, North Carolina, USA
Afshan Hameed, University of California, Irvine, USA
Cases presentations:
Hypertrophic Cardiomyopathy and Pregnancy
Ghadeera Al Mansoori, Cardiology, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates
Rheumatic Mitral Calve Disease and Pregnancy
Fathima Farook, Obstetrics & Gynecology Corniche Hospital, Abu Dhabi, United Arab Emirates
D-Transposition of the Great Vessels and Pregnancy
Fathima Farook, Obstetric Medicine, Corniche Hospital, Abu Dhabi, United Arab Emirates
Panel Discussion (Ob Medicine, High Risk OB, Anaesthesia, Cardiology)
Presentation: Cardio Obstetric Multi-Disciplinary Joint Clinic at Abu Dhabi
The Current Abu Dhabi – UAE Cardio Obstetric Joint Clinic
Ghadeera Almansoori, Cardiology, Corniche Hospital, Abu Dhabi, United Arab Emirates. (15 min)
The International Society of Obstetric Medicine Session
Cardio-Obstetrics: Lessons Learnt over 3 decades
Sam Siu
Western University, London, Canada
Understanding the Management and Outcomes of Pregnant People with Cardiovascular Disease – A Call to Action
John Spertus
Saint Luke’s Health System, Kansas City, USA
How to Build a Cardio Obstetric Team?
Diana S. Wolfe
Montefiore Medical Center, New York, USA
Developing cardio-obstetric teams: Preparing the nursing team
Mary Canobbio
University of California, Los Angeles, Los Angeles, USA
Stories from the Joint Gyneco-Cardio Clinic – Does it improve outcomes?
Hezzy Shmueli
Cardilogy, Soroka Medical Center, Beer Sheva, Israel
Reproductive Health in Women with CVD: A New Approach
Ali Farhan
Baghdad Teaching Hospital, Bagdad, Iraq
Experience with a cardio obstetrics program review of 300 patients and outcomes
Jennifer H. Haythe
Columbia University Irving Medical center, New York, USA
Patient reported health status outcomes in pregnancy
Anna Grodzinsky
Saint Luke’s Mid America Heart Institute, University of Missouri, Kansas, USA
Covid-19
Update on covid
Briller Joan
University of Illinois, Chicago, USA
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19 in U.S. during pandemic year 2020
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Mariland, USA
Risk Prediction and Mortality
Risk Prediction: A 2023 Update
Sam Siu
Western University, London, Canada
Cardiovascular Risk in Pregnancy Over 40
Lee Padove
Northside Hospital, Atlanta, USA
Dynamics of NT-proBNP in Preganacy
Nandita Scott
Massachusetts General Hospital, Harvard Medical School
Biomarkers other than natriuretic peptides in pregnancy
Nandita Scott
Massachusetts General Hospital, Harvard Medical School
Risk stratification of heart disease during pregnancy
Dr Walid Kadro
Cardiology, Abu Dhabi, United Arab Emirates
The troponin is increased what should I do next?
Briller Joan
University of Illinois, Chicago, USA
Prevalence in correlate of elevated NT-proBNP in Pregnant women in the US
Anum Minhas
Cardiology, Johns Hopkins University, Baltimore, USA
The New York experience of the maternal mortality review board
Jennifer H. Haythe
Columbia University Irving Medical center, New York, USA
CVD risk assessment in asymptomatic pregnant and postpartum patients
Afshan Hameed
University of California, Irvine, USA
Choosing the best risk stratification tool for pregnant women with heart disease: what to consider
Anish Keepanasseril
JIPMER, Puducherry, India
Universal CVD screening in pregnancy
Diana S. Wolfe
Montefiore Medical Center, New York, USA
Health Policy Changes that have improved maternal mortality (zoom)
Garima Sharma
Johns Hopkins University School of Medicine, Baltimore, Mariland, USA
Management strategies for adverse pregnancy outcomes
Briller Joan
University of Illinois, Chicago, USA
Artificial Intelligence and Novel Digital Tools for Obstetric Cardiovascular Screening
Demiclad Adedinsewo
Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA
A core outcome set and minimal data set for all future studies on pregnancy and heart disease
Rohan D’souza
McMaster University, Hamilton, Ontario, Canada
Inclusion of pregnant and breast-feeding women in non-obstetrical randomized controlled trial
Dr. Isabelle Malhamé
McGill University, Montreal, Canada
Infertility and contraceptives in women with cardiac disease
IVF: Is it an independent risk for bad outcome
Lee Padove
Northside Hospital, Atlanta, USA
Fertility care in the cardiac patient
Yalda Afshar
Obstetrics and Gynecology, UCLA, Los Angeles, USA
Poly Cystic Oovarian Syndrome, Infertility, and use of Assisted Reproductive Technology: Risk Markers for Cardiac Complications in Pregnancy
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
Infertility in Women with Cardiac Disease: Considerations for the Cardiologist
Jasmine Grewal
University of British Columbia, Vancouver, Canada
Contraceptive updates for the cardiac patient: current use and best practices (data from HOPE pilot study)
Karen Florio
University of Missouri, Columbia, Missouri, USA
Fertility management in Turner Syndrome
Norbert Gleicher
Center of Human Reproduction New York and Foundation for Reproductive Medicine, USA
Pregnancy and Medical problems
Lipids in Pregnancy Does it matter?
Lee Padove
Northside Hospital, Atlanta, USA
Addressing Cardiometabolic Health in the Pre-pregnancy time frame (zoom)
Garima Sharma
Johns Hopkins University School of Medicine, Baltimore, Mariland, USA
The Not So Sweet Truth: Gestational Diabetes and Cardiovascular Complications During Pregnancy and Beyond
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
Obesity complications management during pregnancy
Briller Joan
University of Illinois, Chicago, USA
Treatment of lipid disorders in pregnancy
Laura Schmidt
Saint Luke’s Health System, Kansas City, USA
Is the importance of the immune system underestimated in cardiovascular diseases in pregnancy?
Norbert Gleicher
Center of Human Reproduction New York and Foundation for Reproductive Medicine, USA
Autoimmune disease and Cardiac Complications in Pregnancy
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
The association of diet with adverse pregnancy outcomes
Anum Minhas
Cardiology, Johns Hopkins University, Baltimore, USA
General
Genetics and the cardiac patient
Yalda Afshar
Obstetrics and Gynecology, UCLA, Los Angeles, USA
Cardio-genetics
Melissa Russo
Women & Infants Hospital, Brown University, Providence, Rhode Island, USA
Serious Maternal Cardiac Complications During Pregnancy
Candice Silversides
Mount Sinai Hospital, Toronto, Canada
As older women are getting pregnant, cardiovascular diseases increase
Norbert Gleicher
Center of Human Reproduction New York and Foundation for Reproductive Medicine, USA
Severe Pregnancy-related Cardiovascular Morbidity
Dr. Isabelle Malhamé
McGill University, Montreal, Canada
Registries
Pregnancy outcomes in women with heart disease: The Madras medical college Pregnancy And Cardiac (M-PAC) Registry from India
Gnanaraj Justin Paul
Madras Medical College, Chennai, Tamil Nadu, India
Pregnancy and Labor in Women with Heart Diseases. 30 years’ experience of 800 pregnancy. The Israel northern registry
Eli Gutterman
Carmel Medical Center & Clalit Health Services, Israel
Aortopathies and PROWGAD registry
Melissa Russo
Women & Infants Hospital, Brown University, Providence, Rhode Island, USA
Update on the REBIRTH Multi-center Trial and the North American Peripartum Cardiomyopathy Network
Dennis McNamara
University of Pittsburgh, Pittsburg, USA
Update on PPCM-R, a patient directed PPCM registry
Sarah Thordsen
University of Pennsylvania, Philadelphia, USA
Peripartum cardiomyopathy and Subsequent Pregnancy: Results from the PPCM EORP program (unpublished data)
Karen Sliwa
Cape Heart Institute, Department of Medicine and Cardiology, University of Cape Town, South Africa
Updates on the HOPE study pilot: maternal and fetal outcomes registry
Karen Florio
University of Missouri, Columbia, Missouri, USA
The HOPE (Heart Outcomes in Pregnancy: Expectations) for Mom and Baby Study Pilot data (patient characteristics, pregnancy to 1-year post partum data) – Cardiovascular Outcomes
Anna Grodzinsky
Saint Luke’s Mid America Heart Institute, University of Missouri, Kansas, USA
Cardiomyopthy, Myocarditis Heart Failure and Pericardial disease
Case report: Pregnancy in Probable End stage Loffler’s Myocarditis
Lee Padove
Northside Hospital, Atlanta, USA
Management of women with LV noncompaction during pregnancy
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Heart failure/cardiomyopathy and Inotropic and Mechanical support peridelivery
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
Pregnancy After Cardiotoxic Cancer Treatment
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Should patients with HFrEF be anticoagulated during pregnancy and postpartum period?
Hezzy Shmueli
Cardiology, Soroka Medical Center, Beer Sheva, Israel
Consideration in timing of LVAD and transplantation in patient with Pregnancy Associated LV Dysfunction (Case)
Jennifer H. Haythe
Columbia University Irving Medical center, New York, USA
Hypertrophic cardiomyopathy and pregnancy – expected complications
Sorel Goland
Kaplan Medical Center, Rehovot, Israel
Cardiac transplantation: Developing risk profile for post-transplant females desiring to become pregnant
Mary Canobbio
University of California, Los Angeles, Los Angeles, USA
Pericardial disease in pregnancy
Laura Schmidt
Saint Luke’s Health System, Kansas City, USA
Team management of pregnancy and delivery in a woman with severe hypertrophic cardiomyopathy
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
Risk of Heart Failure in Women with Cancer Survival During and After Pregnancy
Ali Farhan
Baghdad Teaching Hospital, Bagdad, Iraq
High risk delivery in the cardiac ICU with PA catheter placement in a patient with hypertrophic cardiomyopathy (Case)
Anum Minhas
Cardiology, Johns Hopkins University, Baltimore, USA
Racial and Ethnic Disparities in Heart Failure during Pregnancy and Postpartum
Demiclad Adedinsewo
Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA
The risk of pregnancy in women with HFrEF
Avraham Shotan
Laniado medical center, Netanya, Ariel university, Israel
Vascular
Management of aortopathies during pregnancy
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Aorta pathology and pregnancy
Jolien Roos-Hesselink
Erasmus Medical Center, Rotterdam, The Netherlands
Consideration of referal for Prophylactic Aorta Surgery in Bicuspid valve aortopathy
Lee Padove
Northside Hospital, Atlanta, USA
Pregnancy in women with Ehlers-Danlos syndrome
Michal Simchen
Sheba Medical Center, Tel Aviv University, Israel
Pregnancy and Contraception Considerations in Individuals with Aortopathy
Melissa Russo
Women & Infants Hospital, Brown University, Providence, Rhode Island, USA
Aortic Dissection in Pregnancy: Risk Factors, Diagnosis and Treatment
Melissa Russo
Women & Infants Hospital, Brown University, Providence, Rhode Island, USA
Treatment of May Thurner Syndrome during pregnancy
Laura Schmidt
Saint Luke’s Health System, Kansas City, USA
Labor and delivery in patients with marfan syndrome. When and how. (A story of three sisters).
Eli Gutterman
Carmel Medical Center & Clalit Health Services, Israel
Pregnancy and Marfan Arthropathies: Current Approach
Rafael Kuperstein
Sheba Medical Center, Tel Aviv University, Israel
Turner’s Syndrome and Pregnancy
Matthew Cauldwell
Imperial College London and St George’s Hospital, London, United Kingdom
Pregnancy and Takayasu arteritiis: The risk to the mother and the fetus
Abha Khandelwal
Cardiovascular Medicine, Stanford University, USA
Coronary Artery Disease
Debate: Conservative Acute Coronary Syndrome Treatment vs. Invasive Aggressive
Lee Padove
Northside Hospital, Atlanta, USA
Lessons from the UK registry of SCAD
Matthew Cauldwell
Imperial College London, London, United Kingdom
SCAD in pregnancy – management considerations
Uri Elkayam
University of Southern California, Los Angeles, USA
The risk of pregnancy in patients with a history of SCAD (zoom)
Marysia S Tweet
May Clinic, Rochester, USA
Risk stratification and management of pregnancy in a patient with chronic coronary artery disease
Uri Elkayam
University of Southern California, Los Angeles, USA
Anesthetic considerations in patients with Ischaemic Heart Disease or Myocardial Infarction in Pregnancy
Bhatia Kailash
Anesthesiology, Manchester University NHS FT, United Kingdom
Management During Labor and Delivery
The management of the second stage of labor, who should and should not push?
Mark Johnson
Imperial College London, United Kingdom
Labor management and birth in the cardiac patient
Yalda Afshar
Obstetrics and Gynecology, UCLA, Los Angeles, USA
Timing and mode of birth in the pregnant patient with cardiac disease
Yalda Afshar
Obstetrics and Gynecology, UCLA, Los Angeles, USA
Hemodynamics perideivery, the anesthesiologist’s perspective
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
Hemodynamics perideivery, the Cardiologist’s perspective
Uri Elkayam
University of Southern California, Los Angeles, USA
Anesthesia for cardio-thoracic surgery in pregnancy
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
Critical Care Considerations in Pregnancy
Jasmine Grewal
University of British Columbia, Vancouver, Canada
Neuraxial analgesia for labor and delivery in the patient with cardiovascular disease
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
How to Establish Cardiac Monitoring and Nursing on Labor and Delivery?
Diana S. Wolfe
Montefiore Medical Center, New York, USA
What is best gestational age to deliver in the cardiac patient?
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
Labor analgesia in pregnant patients with heart disease – Beyond the epidural?
Bhatia Kailash
Anesthesiology, Manchester University NHS FT, Great Britain
Demystifying the anesthetic management of parturient with complex cardiac disease
Kaitlyn Brennan
Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Designing a mother friendly ICU: considerations for optimizing antepartum and postpartum care outside of L&D
Kaitlyn Brennan
Anesthesiology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Congenital
The impact of pregnancy on cardiac function in women with a Fontan circulation
Mark Johnson
Imperial College London, United Kingdom
Preconception and pregnancy management of the woman born with Ebstein’s anomaly of the tricuspid valve
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Unoperated Congenital Heart Disease and Pregnancy: Results from the ROPAC study (zoom)
Karen Sliwa
Cape Heart Institute, Department of Medicine and Cardiology, University of Cape Town, South Africa
Pregnancy in women with Velo-Cardiac-Facial syndrome (22q11.2 deletion) incl. di George syndrome
Eli Gutterman
Carmel Medical Center & Clalit Health Services, Israel
Evaluating Heart Failure in the pregnant patient with Congenital Heart Disease
Doreen DeFaria Yeh
Cardiology, Massachusetts General Hospital, Boston, USA
Pregnancy in Fontan patients: should we refine the current recommendations?Magalie Ladouceur
Hôpital Européen Georges Pompidou, Paris, France
The effect of pregnancy on long term echocardiographic parameters of women with congenital heart disease
Efrat Mazor Dray
Sheba Medical Center, Ramat Gan, Israel
Tetralogy of Fallot and Pregnancy
Efrat Mazor Dray
Sheba Medical Center, Ramat Gan, Israel
Tetralogy of Fallot: a single eponym for a wide spectrum: Prenatal diagnosis and fetal and neonatal implications
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam ,The Netherlands
Pregnancy in women with Ebstein’s anomaly
Jolien Roos-Hesselink
Erasmus Medical Center, Rotterdam, The Netherlands
Maternal and fetal outcome of pregnancy in women with D-transposition of the great arteries-A systemic review
Jena Pizula
University of Southern California, Los Angeles, USA
Maternal and fetal outcome of pregnancy in women with congenitally corrected transposition of the great arteries- a systemic review
Jena Pizula
University of Southern California, Los Angeles, USA
Valvular
The latest view of the management of women with metallic heart valves in pregnancy
Mark Johnson
Imperial College London, United Kingdom
Pregnancy in women with Rheumatic heart disease – the US perspective
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Obstetric management of pregnancy in women with prosthetic valves
Michal Simchen
Sheba Medical Center, Tel Aviv University, Israel
Rheumatic Heart Disease and Pregnancy – Still a major problem to deal with
Hezzy Shmueli
Cardiology, Soroka Medical Center, Beer Sheva, Israel
Managing patients with mitral stenosis during pregnancy
Rafael Kuperstein
Sheba Medical Center, Tel Aviv University, Israel
Individualizing care for pregnant individuals with mechanical heart valves – an evidence-based, patient-centered approach
Rohan D’souza
McMaster University, Hamilton, Ontario, Canada
Risk scores for rheumatic valvular heart: an update
Dr. Anish Keepanasseril
JIPMER, Puducherry, India
Regurgitation Valve Disease in Pregnancy
Candice Silversides
Mount Sinai Hospital, Toronto, Canada
Rheumatic Valvular Heart disease and Pregnancy: Challenges from a low to middle income patient-populations
Anish Keepanasseril
JIPMER, Puducherry, India
Alternative to LMWH as anticoagulation in pregnant women with mechanical heart valves in middle income countries
Anish Keepanasseril
JIPMER, Puducherry, India
Peripartal anticoagulation in women with mechanical valves
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
TAVR during pregnancy – advantages and limitations
Anil Mehra
University of Southern California, Los Angeles, USA
Mechanical Heart Valves in pregnancy –What an anesthesiologist should know?
Bhatia Kailash
Anesthesiology, Manchester University NHS FT, Great Britain
Anaesthetic consideration in patients with severe mitral and aortic stenosis
Bhatia Kailash
Anesthesiology, Manchester University NHS FT, Great Britain
Cardiac Evaluation and Imaging
Exercise and stress testing during pregnancy
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Utility of point of care ultrasound on labor and delivery
Amir Shamshirsaz
Baylor College of Medicine, Houston, Texas, USA
What everyone needs to know about lung ultrasound?
Amir Shamshirsaz
Baylor College of Medicine, Houston, Texas, USA
Management of pregnancy in women with congenital heart disease – what is the role of multi-modality imaging?
Rachel Wald
Echocardiographic changes in normal pregnancy
Tasneem Naqvi
Cardiology, Mayo Clinic, Phoenix, Arizona, USA
Drugs in Pregnancy
Medical treatment during pregnancy
Marla Mendelson
Northwestern Feinberg School of Medicine, Chicago, USA
Transplacental Passage of Drugs: Principles and Predictions
Irving Steinberg
School of Pharmacy, University of Southern California, Los Angeles, USA
Precision Dosing in Pregnancy: The Need and Potential in the Cardiac Patient
Irving Steinberg
School of Pharmacy, University of Southern California, Los Angeles, USA
Heparin Dosing in Pregnancy: Regimen Design to Meet Guidelines
Irving Steinberg
School of Pharmacy, University of Southern California, Los Angeles, USA
Beta blocker Considerations among Pregnant Women with Cardiac Disease
Jasmine Grewal
University of British Columbia, Vancouver, Canada
Medications – Results from ROPAC
Jolien Roos-Hesselink
Erasmus Medical Center, Rotterdam, The Netherlands
Mechanical Heart Valves – Anticoagulation in Pregnancy
Catherine Nelson-Piercy
Obstetric Medicine, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Hypertension and Preeclampsia
Long term consequences of preeclampsia in pregnancy
Michal Simchen
Sheba Medical Center, Tel Aviv University, Israel
Term and Early onset pre-eclampsia what are the future risks
Matthew Cauldwell
Imperial College London and St George’s Hospital, London, United Kingdom
What should the target for BP treatment in pregnancy – <140/90 or<130/80?
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
Statins for Preeclampsia Prevention
Erin Michos
Cardiology, Johns Hopkins Hospital, Baltimore, Maryland, USA
Pregnancy in women with heart disease complicated by pre-ecclampsia or thrombophilia
Eli Gutterman
Carmel Medical Center & Clalit Health Services, Israel
Hypertensive Disease in Pregnancy: Individualization of Pharmacotherapy
Irving Steinberg
School of Pharmacy, University of Southern California, Los Angeles, USA
Pathophysiology of preeclampsia
Dr Walid Kadro
Cardiology, Abu Dhabi, United Arab Emirates
Uterotonics and hemorrhage management in the patient with preeclampsia
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
Hypertensive disorders of pregnancy: what is the goal?
Afshan Hameed
University of California, Irvine, USA
Maternal hemodynamic assessment using ultrasound for the prevention and management of hypertensive disorders of pregnancy
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
Postpartum endothelial function and risk with CVD in preeclampsia
Anum Minhas
Cardiology, Johns Hopkins University, Baltimore, USA
Peripartum Cardiomyopathy
Genetics of PPCM (zoom)
Arany Zoltan
University of Pennsylvania, Philadelphia, USA
Back to the Crime Scene – Pregnancy following PPCM – Our experience and Update
Hezzy Shmueli
Cardiology, Soroka Medical Center, Beer Sheva, Israel
Use of injectable loop recorders in peripartum women (zoom)
Karen Sliwa
Cape Heart Institute, Department of Medicine and Cardiology, University of Cape Town, South Africa
Pathology of prepartum cardiomyopathy
Dr Walid Kadro
Cardiology, Abu Dhabi, United Arab Emirates
Peripartum Cardiomyopathy with and without Hypertensive Disorders of Pregnancy: Are they different Disorders?
Dennis McNamara
University of Pittsburgh, Pittsburg, USA
Bromocriptine as adjunctive treatment for peripartum cardiomyopathy – study protocol for a multi-country randomized controlled study
Rohan D’souza
McMaster University, Hamilton, Ontario, Canada
Hemodynamic phenotypes of peripartum cardiomyopathy can predict the recovery rate
Sorel Goland
Kaplan Medical Center, Rehovot, Israel
Rebirth Study – Status report
Uri Elkayam
University of Southern California, Los Angeles, USA
Subsequent pregnancy in women after PPCM – The Israeli experience
Sorel Goland
Kaplan Medical Center, Rehovot, Israel
Mental Health in PPCM Survivors and Partners
Sarah Thordsen
University of Pennsylvania, Philadelphia, USA
Pregnancy-Related Cardiomyopathy & Cardiovascular Risk Assessment: Are Symptoms Enough?
Demiclad Adedinsewo
Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida, USA
Recovery of cardiac function after peripartum cardiomyopathy: A cure or a remission?
Uri Elkayam
University of Southern California, Los Angeles, USA
Quantifying the quality of life of patients with peri-partum cardiomyopathy
John Spertus
Saint Luke’s Mid America Heart Institute, University of Missouri, Kansas City, Missouri, USA
Arrhythmias
Cardioversion in Pregnancy
Matthew Cauldwell
Imperial College London, London, United Kingdom
‘Syncope in Pregnancy – a safe approach for the Internist and Obstetrician’
Paul S. Gibson
University of Calgary, Calgary, Canada
Maternal cardiac arrest and ECPR
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
Cardiac Arrest on Labor and Delivery
Diana S. Wolfe
Montefiore Medical Center, New York, USA
Prenatal diagnosis, differentiation and management of fetal arrhythmia’s.
Fetal Speckle echocardiography
Jérôme Cornette
Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands
POTS
Lee Padove
Northside Hospital, Atlanta, USA
Pregnancy in women with arrhythmogenic cardiomyopathy
Silvia Castelletti
Cardiology, IRCCS Istituto Auxologico Italiano, Milan, Italy
Approach to arrhythmia symptoms and management in pregnancy
Danna Spears
Toronto General Hospital, Toronto, Canada
Bradyarrhythmias and cardiac rhythm device implantation and management in pregnancy
Danna Spears
Toronto General Hospital, Toronto, Canada
Inherited arrhythmia and Pregnancy
Danna Spears
Toronto General Hospital, Toronto, Canada
Pulmonary HTN and PE
Pulmonary Hypertension in the Congenital Pregnant Patient
Candice Silversides
Mount Sinai Hospital, Toronto, Canada
Pulmonary hypertension in pregnancy
Hani Sabbour
Cardiology, Abu Dhabi, United Arab Emirates
Pulmonary hypertension and pregnancy, management peridelivery
Marie-Louise Meng
Duke University Medical Center, Durham, North Carolina, USA
World Data and Clinical Management Protocol for Pregnant Women with PAH. (zoom)
Dianne Zwicke
Aurora St. Luke’s Medical Center, Milwaukee, USA
Overview of venous disease in pregnancy
Laura Schmidt
Saint Luke’s Health System, Kansas City, USA
Case Study of Patient with PAH, Real Time Management, and 5th type of Atrial level shunt (zoom)
Dianne Zwicke
Aurora St. Luke’s Medical Center, Milwaukee, USA
Venous thromboembolism in pregnant women
Catherine Nelson-Piercy
Obstetric Medicine, Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
